Introduction
Mutagenicity testing is beginning to find a place as a factor in evaluation of the safety of compounds to which the human population is exposed. The mutation systems selected for such tests should ideally involve in vivo studies with mammals and encompass scoring of a broad spectrum of mutational events including both transmissible chromosome aberrations and point mutations. The frequency of chromosome aberrations obtained after a certain treatment can be assessed quantitatively without prohibitive costs and effort. At the present time there is only one proven system which can be used to screen for specific locus mutations in mammals in vivo; the seven specific locus system of Russell. On the other hand there are many microbial systems in which point mutation frequencies can be easily determined quantitatively. It is a known fact, however, that mammals can convert nonmutagenic compounds (promutagens) to highly mutagenic metabolites and that these promutagens are not mutagenic in microorganisms (1) . In order to combine the drug metabolism of the mammal with the excellence of the microbial systems for measuring point mutations, the host-mediated assay (1) and the microsomal system (2) were developed. In the host-mediated assay the indicator organism is injected into the animal by one route and the promutagen or mutagen is administered preferably by a different route. The indicator organism is then later recovered and the induced mutation frequency is scored among the recovered cells. In the microsomal system the indicator organism is mixed directly into the reaction mixture containing microsomes, cofactors, and the drug. After a certain reaction time the cells are recovered again and screened for presence of mutants.
Dimethylnitrosamine (DMN) and diethylnitrosamine (DEN) are two chemicals which are nonmutagenic by themselves but which are converted to mutagenic substances by hydroxylation (3) . DMN is converted to a highly mutagenic compound in the hostmediated assay (1) or in the microsomal system (2) . Both DMN and DEN are potent tissue-specific carcinogens in many animal species. The tumorigenic activity of these compounds seems somewhat related to the presence of the activation enzymes (4) (5) (6) Lowry (8) . Microsomes prepared this way correlate well in enzyme content and enzyme reaction with the microsomes pelleted by centrifugation at 100,000g (7, 9) .
Individual Components of the Reaction Mixture
The microsomal reaction mixture is complex. In order to investigate the importance of each component, the formation of mutagenic metabolites was measured in mixtures from which the components were deleted one at a time. Table 1 indicates clearly that they are all necessary. In the case in which N2 was used instead of O2, there was no mutagenesis indicating that the formation of the active metabolites was an oxidation process. It was also clear that the formation of the mutagenic metabolites required NADPH which indicated that the activation of DMN was enzymatic. Only in the case where MgCL2 was omitted was there any residual activity, probably due to the fact that the micromomes already contained a certain amount of Mg+.
Microsomal Inhibitors
SKF 525-A is a well-known general microsome inhibitor (10) . Its ability to stop the formation of mutagenic metabolites was tested on the 20,000g supernatant from homogenized livers of male mice (B6D2F1). The first step in the metabolic activation of aliphatic nitrosamines is probably hydroxylation of the carbon next to the nitrogen. The subsequent steps may be spontaneous resulting in formation of a carbonium radical and an aldehyde (11) . In the case of DMN the aldehyde is formaldehyde. This is the product which was determined during enzyme activity studies.
Mutagenicity of Formaldehyde
Although formaldehyde is generally considered to be the nonactive metabolite of DMN, it has nevertheless been shown to be a weak mutagen in several organisms (12, 13 Table 2 shows the reverse mutation frequency of G46 obtained upon treatment with DMN using various concentrations of the 20,000g supernatant in the reaction mixture. It is clear from Table 2 that there is no direct proportionality between the amount of supernatant and the reverse mutation frequency.
By working with a pure microsome preparation, we can simultaneously measure the reverse mutation frequency in one assay and the activity of microsomal demethylase by the formation of formaldehyde. Figure 1 shows the frequency of reverse mutations in G46 after DMN treatment using various amounts of purified microsome in the reaction mixture. The data presented on this Figure 1 are in good agreement with the data presented in Table 2 obtained with the 20,000g supernatant. Figure 2 shows the correlation between reverse mutation frequencies and the formaldehyde production. It is clear from this figure that only after a certain amount of metabolism was there a linear increase in the reverse mutation frequency. It appeared that the active metabolite has to reach a critical concentration or critical total amount before a large number of mutations are induced. After this point was reached, the reverse mutation frequency increased proportionally with the increasing production of formaldehyde. This apparent "threshold" could be due to (a) the presence of a certain number of reactive groups in the reaction mixture which had to be saturated by the active metabolites before any appreciable amount was left over for induction of mutations, (b) a concentration effect on transport across the bacterial cell wall, or (c) certain unique characteristics of the reverse mutation sites in strain G46. Enzyme Induction The drug-metabolizing enzymes of the liver can be increased by administering certain compounds to the animal. Phenobarbital and 3-methylcholanthrene (3-MC) are some of the generally used inducers of drugmetabolizing enzymes. Table 3 gives the reverse mutation frequency in strain G46 after treatment with DMN in the microsomal system with the 20,000g supernatant. Some of the animals had been pretreated with phenobarbital or 3-MC by intraperitoncal (IP) injections or by prefeeding with butylated hydroxytoluene (BHT). It is clear from these data that pretreatment with all three inducers resulted in an increase in the mutagenic activity of the microsomal system with both DMN and DEN. aLivers from at least three male mice were pooled to obtain each mutant frequency. The 20,000g supernatant of the liver homogenate (2 ml solution/liver) was incubated with 4 mg TPNH, Salmonella typhimur.um, and DMN or DEN for 20 min. Sodium phenobarbital was given IP, b.i.d., doses of 80/mg/kg-day for 3 days, the last injection 12 hr prior to sacrifice. Age-matched controls were given corresponding injections of saline. 3-Methylcholanthrene, 0.5 mg in 0.5 ml olive oil, was injected IP 24 hr prior to sacrifiee; age-matched controls received 0.5 ml olive oil. BHT was fed to animals as 0.75% of diet for 14 days.
ad-3 Mutation System in Neurospora crassa, This mutation system is based on detection of forward-mutations in two adenine genes, ad-3A and ad-3B (14) . Mutants in the two genes block the purine biosynthesis in two sequential steps, and lead to accumulation of purple pigments in the mycelium. The mutants are detected as purple colonies among white nonmutated colonies. The colonies are grown submersed, and it is easy to screen 50 x 106 colonies in a day. Neurospora is normally haploid but forms heterokaryons. A heterokaryon heterozygotic for the two adenine-genes, ad-3A and ad-3B, is white. The heterokaryons mimic the diploid cells in many ways. Purple ad-3 mutations induced in such a heterokaryon can be point mutations in either of the two genes or deletion of either one or both of the genes. The ad-3B mutants can either be noncomplementing or have a polarized or nonpolarized complementation pattern. The ad-3.A mutants do not show complementation.
Work with the reverse mutation frequencies in various mutants induced by a series of specific chemical mutagens and with the complementation response of the mutant shown that there are many different mutational sites in both loci (15) (16) (17) . From growth studies it is known that the mutants recovered in de Serres' forward mutations system ranged from mutants totally dependent on adenine to mutants which can grow with wild-type rate on minimal medium (18) . We can, therefore, conclude that in this system a broad spectrum of mutational damage can be detected.
It has previously been established that DMN and DEN do not induce mutations in directly treated Neurospora conidia. However, in a chemical system which mimics the liver metabolism of these two compounds (3), both DMN and DEN are mutagenic. Thus, the active metabolites of DMN and DEN are mutagenic in Neurospora.
The Salmonella typhimurium His G46 Locus Salmonella normally do not require histidine to grow. However, Ames (19) Comparison of Indicator Organisms Table 4 shows the frequency of ad-3 mutations obtained among Neurospora conidia injected into the peritoneal cavity of mice when the mice were treated with DMN and the frequency of histidine revertants induced in S. typhimurium G46 under similar conditions.
It is clear that the reversion sites in G46
are much more sensitive than the a-3 loci of Neurospora. This is a surprising result, since in G46 the mutations induced in a few codons are being measured, whereas in Table 5 shows the results obtained in an host-mediated assay with the use of Neurospora as the indicator organism and treatment of the animal with either DMN or DEN. Several routes of administration were used; the conidia were injected either IP or into the tail vein (IV). With IV injection a portion of the conidia are trapped in the liver and lungs of the animal. Biopsies have shown the conidia well dispersed.
Upon assay of the promutagen DEN, no effect was found when the Neurospora were injected IP, and a slight increase in mutation frequency over control was observed in conidia injected IV and recovered from the liver. Similarly, DMN did not increase the mutation frequency of IP conidia above the control and in Neurospora injected IV and isolated from the liver, DMN increased the mutant frequency dramatically. Environmental Health Perspectives An explanation of these results must take -bo-lites is clearly demonstrated in the next into account both anatomy and metabolism.
series of experiments. In the mouse microWe suggest that the highly reactive metasome system, under the same conditions unbolites of DMN and DEN are extremely der-which DMN induced 100-200 revertants short-lived and cannot easily survive trahs--per-106 survivors in bacteria, only 5 ad-3 port from the liver, where the metabolites mutations per 106 survivors were found in are primarily formed, to the peritoneum. -Neurospora (Ong, personal communicaHowever, when the conidia are sitting in tion). In Neurospora conidia injected IV and the liver, they may easily come into close recovered from the liver, the ad-3 mutation contact with the active metabolites.
frequency is 250 per 106 survivors. It is difficult to make comparisons of data In summary of this discussion of alterobtained from the host-mediated assay with native assay methods, we are looking for that obtained from microsomal mutagenesis a mutagenesis assay which is the most senassays. In the host-mediated assay, the sursitive in the detection of mammalian metavival of the host is the determining factor bolism of a promutagen to mutagenic but for maximum dose; in the microsomal syslabile products. The Salmonella G46 data tem some efficiency of metabolism may be indicate that an in vitro microsomal system lost. However, the magnitude of the differ- show very high mutagenic activity in either conclusion was reached above when the musystem (Table 7) . One surprising result is tagenicity of DMN in Neurospora conidia that, in comparison with the results from in intraperitoneal and intrahepatic (IH) the host-mediated assay, DMN did not show locations were compared. a very high mutagenicity in the rat liver Nevertheless, the inefficiency of using the microsome system. A possible explanation microsomal system to form mutagenic meta-for that is that in the host-mediated system, one utilizes the total rat liver, which is much bigger than the mouse liver, whereas in the microsomal system the same amount of liver from both mice and rats was used.
Mouse Strains
In evaluation of the safety of chemicals for the human population an everpresent dilemma is the selection of the proper mammalian species and within the species the strain. As noted previously in the introduction, great differences exist between rats and mice. Table 8 gives the comparison between mouse strains C57BL/6, DBA2/J, and the hybrid of the two strains, B6D2F1. Strain C57BL/6 has lower activity than DBA2/J, which has the same activity as the Fl hybrid between the two strains. Table 9 gives similar results obtained with another " Three animals of each strain, which had been housed and fed under similar conditions for at least 2 weeks and who were matched for age, were pooled to determine each mutant frequency. Livers were homogenized in 2.5 ml solution/liver, and equal amounts of 20,000g supernatant were incubated with 180 mM, DMN, 4 mg TPNH, and Salmonella typhimurium for 20 min. Table 9 shows clearly that similar differences did not exist for activation of DEN. We think these data indicate the enzymes activating DMN and DEN are different. S. typhimurium G46 reverts after treatment in the microsomal systems mixed with DEN at a much lower rate than when mixed with DMN. Since the mutation activity is Environmental Health Perspectives scored as revertants, it could be an expression of the specificity of the reverse mutation mechanism and not a difference in activity of the enzymes. However, in a hostmediated assay with Neurospora as indicator organism in which the conidia were injected IV and recovered from the liver, the ad 3 mutation frequency among the conidia after DMN treatment of the animal was 500 times higher than after treatment of the animal with DEN. Thus, the difference in the mutagenicity of DMN and DEN are consistent with different indicator organisms, and we can conclude that the results obtained with G46 probably are due to difference in enzyme activity and not due to specificity in reversion mechanism for active products of these two chemicals.
In line with these observations, the data in Table 10 shows that there is very little increase in the reversion frequency when the DEN concentration is varied from 25 mM to 200 mM.
Purified Microsomes and Strain Differences
A better understanding of the basis for the strain differences and the difference between induced and noninduced animals can be obtained by using purified microsomes. The two most extreme mouse strains with Livers from three male B6D2F1 mice were homogenized in 2 ml of buffered solution per gram liver.
The 20,000g supernatant was incubated with 4 mg TPNH, DEN, and Salmonella for 20 min.
respect to their ability to form mutagenic metabolites were selected for the experiment. They were C57BL/6 (the low activity strain) and C3H (the high activity strain). 3-MC was used as an enzyme inducer. In Table 11 All mice were males matched for age and raised in the same environment for at least 2 weeks prior to sacrifice. 3-Methylcholanthrene, 0.5 mg in 0.25 ml olive oil, was injected IP 24 hr prior to sacrifice; controls received 0.25 ml olive oil IP. Pools of three animals were used to determine each data point. Microsomes were prepared according to the method of Kupfer and Levin (7); protein was measured by the Lowry technique (8). Identical 15-min incubations were done for formaldehyde production and bacterial mutagenesis, except no bacteria were present in the demethylase assay. Incubation contained lOOmM DMN, 1.6 mg microsomal protein/ml, 1.6 mg TPNH/ml, pH 7.5 buffer, and either water or Salmonella typhimurium in 0.9% saline. demethylase activity per milligram protein is almost the same.
Another question raised is the correlation between mutagenic activity and demethylase activity when different strains are considered and they are induced with 3-MC. By plotting in the data obtained from under these various conditions on the curve describing the relationship between demethylase activity and reversion frequency (Fig.  3) , a very good agreement was demonstrated between demethylase and reversion frequency independent of the variation with respect to strain and to induction with 3-MC. Table 11 .
It is interesting to note that the mouse strain with the lowest basic demethylase activity is the strain which is most inducible, and when both are induced, this relationship between strains in terms of demethylase activity is reversed.
Discussion
Both DMN and DEN require metabolic conversion before becoming mutagenic. Both compounds probably form highly labile active intermediates. The degree of reaction with DNA is likely to depend on the presence of activating enzymes. After treatment of an animal with DMN, the DNA of the various tissues are alkylated to greatly different degrees. The testes are among organs alkylated the least. After treatment of mice with MMS or DMN in equal doses the amount of alkylation measured as 7-methylguanine in the DNA of the testis is, respectively, 0.05% and 0.0007%o (4 Ideally, we may want to base the safety evaluation of a compound on mutation systemns based on detection of germinal mutations in vivo in mammals. The question would then be: Does that compound give a significant increase in the frequency of mu-tations? As mentioned earlier, it is unlikely that DMN would give any detectable increase in the number of germinal mutations when the testing is carried out in the standard way. Maybe therefore, in the safety evaluation of a chemical, it would be preferable to take a more conservative posture and base the evaluation on seeking an answer to the following question: Can the mammal convert the chemical under test to a mutagenic metabolite? If so, there is reason for caution. It is in the attempt to answer the question that the host-mediated assay and the microsomal system are potentially most useful.
In assessment of the mutagenicity of environmental compounds it is important that the test system is as relevant to man as possible. The liver microsome system, with the use of human liver microsomes and human cells, represents such a possibility. Most pharmacologists, however, would agree that the liver microsomal system can give false negative results due to lack of, for instance, the right coenzyme or other conditions which are required for the biochemical reactions to proceed.
Summary
In summary, we have explored a number of factors related to mammalian activation of promutagens. We define DMN and DEN as promutagens needing mammalian metabolism to form highly mutagenic products. For DMN the activation is microsomal, needs some cofactors, and the mutagenic activity of the product is directly correlated with the metabolie formation of formaldehyde with and without induction and across strains of-mice. Formaldehyde does not contribute to the mutagenic activity of the reaction products.
Selection of a mammalian metabolizer of promutagens should be made with the variability between species and strains in mind. Induction of* microsomes may increase sensitivity in a given strain.
At lea t.with N-and, DEN, Salmonella G46 is -far more. sensitive than Neurospora as an indicatox;-.organism.
Finally, the proximity of the indicator organism to the major site of metabolism is related to mutagenic activity in terms of orders of magnitude. The microsomal assay is a few orders of magnitude more sensitive than the IP host-mediated assay, and the intrahepatic host-mediated assay is a few orders of magnitude more sensitive than the in vitro microsomal system.
